Targeting the Inhibition of Tryptophan 2,3-Dioxygenase (TDO-2) for Cancer Treatment
- 22 November 2016
- journal article
- editorial
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 8 (1) , 11-13
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- TDO as a therapeutic target in brain diseasesMetabolic Brain Disease, 2016
- Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer ImmunotherapyClinical Cancer Research, 2015
- Targeting key dioxygenases in tryptophan–kynurenine metabolism for immunomodulation and cancer chemotherapyDrug Discovery Today, 2015
- Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan DepletionCancer Research, 2012